Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Biotechnology

Healthcare
$1.61 -0.87%

-$0.02 today

Market cap
$80.25M
Beta
0.00
P/E (TTM)
-16.7
EPS (TTM)
-$0.14
52W Low $2.01High $48.91

Volume 0.02M

Average 0.34M

Price history

Polaryx Therapeutics, Inc. Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-95.40%

Period high

$35.00

Period low

$1.60

Latest

$1.61

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KSep 14, 2026Sep 11, 2026
8-KSep 1, 2026Sep 1, 2026
10-QAug 13, 2026Aug 13, 2026
ARSJul 28, 2026Jul 28, 2026
DEFA14AJul 28, 2026Jul 28, 2026
DEF 14AJul 28, 2026Jul 28, 2026
S-8Jul 24, 2026Jul 24, 2026
8-KJul 21, 2026Jul 21, 2026
8-KJul 17, 2026Jul 17, 2026
4May 28, 2026May 28, 2026
8-KMay 28, 2026May 28, 2026
10-QMay 15, 2026May 14, 2026
10-KMar 24, 2026Mar 23, 2026
4Feb 20, 2026Feb 20, 2026

Competitors

Who does Polaryx Therapeutics, Inc. Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about PLYX's filings, answered from its disclosures.

What is the latest PLYX filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does PLYX have?

Intrinsic Alpha currently shows 20 recent filings for PLYX.